Top Markets
Coin of the day
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Rangering i aksjer #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Aksjekurs
$9.13
Markedsverdi
$39.27K
Endring (1 dag)
0.00%
Endring (1 år)
-11.76%
Land
IE
Handel Malin Corporation plc (MLC)

Kategori

P/B-forhold for Malin Corporation plc (MLC)
P/B-forhold per April 2026 TTM: 0.00
Ifølge Malin Corporation plc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0.00. Ved slutten av 2023 hadde selskapet et P/B-forhold på 0.92.
P/B-historikk for Malin Corporation plc fra 2015 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 0.00 -99.89%
2024 0.85 -7.70%
2023 0.92 4.18%
2022 0.88 -35.57%
2021 1.37 102.96%
2020 0.67 -45.49%
2019 1.23 -13.34%
2018 1.42 -14.42%
2017 1.66 -1.02%
2016 1.68 101.21%
2015 0.84 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
3.128 347,455.56%
FR
1.7723 196,822.22%
DE
1.1696 129,855.56%
JP
15.9323 1,770,155.56%
US
5.1551 572,688.89%
IN